Posted On January 7, 2025 /
By Debbie Muse / Posted in Blog
Dr. Anand Participated in Research on New Gene Therapy Drug for X-linked Retinitis Pigmentosa Published in American Journal of Ophthalmology
The two-year results of the Phase I/II, multi-center HORIZON clinical trial of the new subretinal gene therapy drug AGTC-501 for X-linked retinitis pigmentosa were recently published in the American Journal of Ophthalmology.
read more
Posted On March 22, 2021 /
By Debbie Muse / Posted in Blog
Dr. Choi’s Research on Filtering-associated Endophthalmitis in Ophthalmology Retina Journal
Texas Retina Associates’ Rene Y. Choi, MD, PhD, published an article titled “Filtering-Associated Endophthalmitis after Trabeculectomy or Tube-Shunt Implant” in the March 2021 issue of Ophthalmology Retina. The article highlights the results of
read more
Posted On October 26, 2020 /
By Debbie Muse / Posted in Blog
Dr. Choi’s Research on Utilizing Artificial Intelligence to Aid in the Diagnosis of Plus Disease in Retinopathy of Prematurity Patients Published in Ophthalmology Retina
Texas Retina Associates’ Rene Y. Choi, MD, published an article titled “Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale” in the latest issue of Ophthalmology Retina,
read more